DiaMedica Issues Stock Option Grants
18 April 2018 - 11:00AM
DiaMedica Therapeutics Inc. (the
"
Company") (TSX-V:DMA)
(OTCQB:DMCAF), today announced the issuance of 2,551,000 stock
options to various officers and directors of the Company. The
options were issued at $0.56 per share and have a ten-year term.
The options were granted under the Company's
Stock Option Plan and are part of the Company's long term
incentive/retention plan for employees. The option issuance is
subject to the approval of the TSX Venture Exchange.
About DiaMedica Therapeutics
Inc.
DiaMedica Therapeutics is a clinical stage
biopharmaceutical company focused on developing novel treatments
for neurological and kidney diseases. DiaMedica’s shares are listed
on the TSX Venture Exchange under the trading symbol “DMA” and on
the OTCQB under the trading symbol “DMCAF”. For more information,
please visit www.diamedica.com.
Follow us on social media –
Twitter,
LinkedIn.
Contact:
Paul Papi Vice President of Business Development
DiaMedica Therapeutics Inc. Phone: (617) 899-5941
info@diamedica.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of the contents of this press release.
DiaMedica Inc. (TSXV:DMA)
Historical Stock Chart
From Jun 2024 to Jul 2024
DiaMedica Inc. (TSXV:DMA)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Diamedica Therapeutics (TSX Venture Exchange): 0 recent articles
More News Articles